Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Neogen reports robust Q2 earnings, targets $1B revenue by 2025

Neogen's Q2 2023 earnings call highlighted impressive revenue growth, improved margins, and strategic focus on integration and customer service.
While facing challenges related to increased debt levels and operational complexities, Neogen aims for ambitious revenue and EBITDA targets by 2025.
The company's performance underscores its potential for continued success in the Food Safety and Animal Safety segments through organic growth and financial discipline.

Neogen reports robust Q3 earnings, focuses on data analytics growth

Neogen's Q3 performance reflects strong revenue growth and strategic focus on data analytics for food security. While challenges exist in certain business segments, the company remains optimistic about long-term opportunities and integration synergies.

Neogen reports stellar Q4 results, eyes growth through integration

Neogen's Q4 2023 earnings call highlighted robust financial performance, successful integration of acquired divisions, and strategic outlook for fiscal '24. The company's focus on growth, innovation, and market expansion positions it well for continued success in the food safety and animal health sectors.

Neogen reports robust Q1 earnings, eyes growth amid regional challenges

Neogen's Q1 2024 showed strong revenue growth but faced challenges in core revenue.
The company highlighted progress in key segments like Food Safety and genomics.
Efficiency issues from ERP implementation impacted revenue timing.
Management remains optimistic about the full-year outlook despite regional challenges.

Neogen reports flat Q2 revenues, focuses on integration and market challenges

Neogen's Q2 performance was mixed, with strengths in certain segments and challenges in others. The company remains optimistic about its long-term prospects despite market headwinds.

Neogen reports improved margins in Q3 despite integration challenges

Neogen's Q3 2024 performance showed improvements in gross margin and EBITDA, but challenges with shipping inefficiencies and integration impacted revenue growth. The company is focused on resolving operational inefficiencies and regaining lost customers to achieve long-term growth goals.

Neogen reports Q4 revenue growth but faces EBITDA margin decline

Neogen's Q4 showed mixed performance with revenue growth but declining EBITDA margins.
The company faces challenges in the soft food safety end market and supply constraints.
However, Neogen is focusing on innovation and underpenetrated markets for future growth.

Neogen reports Q1 revenue decline, focuses on food safety growth

Neogen's Q1 performance showed mixed results with revenue decline and EBITDA pressure.
The company's strengths lie in its strategic positioning in food safety and customer-focused approach.
Challenges persist in certain segments, requiring operational adjustments for sustained growth.
Identified opportunities in geographic expansion and strategic investments can drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

NEOGEN's (NEOG) acquisition of CAPInnoVet expands its Animal Safety division and offers a strategic entry into the retail parasiticide market.

NEOGEN (NEOG) to Enter Retail Parasiticide Space With New Buyout

Neogen (NEOG) delivered earnings and revenue surprises of 6.67% and 4.82%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Beats Q1 Earnings and Revenue Estimates

LANSING, Mich., Sept. 21, 2021 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the results of the first quarter of its 2022 fiscal year, which ended August 31.

Neogen Announces Record Revenue in First Quarter

Neogen Corporation (NASDAQ: NEOG) has acquired CAPInnoVet, Inc, an Atlanta-based companion animal health company. Deal terms were not disclosed.

Neogen Acquires CAPInnoVet For Undisclosed Sum

LANSING, Mich., Sept. 20, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that it has acquired Atlanta-based CAPInnoVet, Inc., a companion animal health company that provides pet medications to the veterinary market.

NEOGEN Acquires CAPInnoVet, Inc.

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?

Neogen (NEOG) Down 4.1% Since Last Earnings Report: Can It Rebound?

LANSING, Mich., July 28, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that they have launched a test that can quickly and accurately detect levels of the delta-9-tetrahydrocannabinol (Δ9-THC) cannabinoid in hemp plants.

NEOGEN Launches Reveal® Q+ for Δ9-THC in Hemp

Neogen's fiscal fourth quarter was mixed, with supply chain and logistics issues offsetting a modest top-line beat with double-digit revenue growth.

Robust Valuation Leaves Neogen Little Room For Error After Mixed Results

Strong segmental revenues and solid international performance across Neogen's (NEOG) entire business drove its topline.

Neogen (NEOG) Misses Q4 Earnings, Tops Revenue Estimates

Neogen Corporation (NEOG) CEO John Adent on Q4 2021 Results - Earnings Call Transcript

Neogen Corporation (NASDAQ: NEOG) reported a Q4 net income of $0.15 per share, missing a consensus estimate of $0.16  Q4 Revenues increased 17% Y/Y to $127.4 million ahead of the analysts' estimate of $122.3 million.

Supply Chain Issues Hit Neogen's Q4 Margins, Earnings

Shares of Neogen (NASDAQ:NEOG) decreased 0.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 51.61% over the past year to $0.15, which missed the estimate of $0.16.

Neogen: Q4 Earnings Insights

LANSING, Mich., July 20, 2021 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the results for its fourth quarter and full 2021 fiscal year, which ended May 31, 2021.

Neogen Reports Record Revenues for Fiscal 2021

Neogen (NASDAQ:NEOG) announces its next round of earnings this Tuesday, July 20. Here is Benzinga's look at Neogen's Q4 earnings report.

Earnings Outlook For Neogen

Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Neogen (NEOG) to Report Q4 Results: What You Should Expect

LINCOLN, Neb., June 28, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that they have extended their strategic partnership with genomics software company Gencove, Inc. to continue providing robust and innovative animal genomic testing.

NEOGEN, Gencove Extend Animal Genomics Partnership

NEOGEN (NEOG) together with CAT can enable members of the aquaculture sector to make more informed breeding decisions.

NEOGEN (NEOG) Enhances Aquaculture Genotyping With New Pact

LINCOLN, Neb., June 24, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with the Center for Aquaculture Technologies (CAT) to deliver high-quality genotyping services customized to the unique needs of aquaculture producers.

NEOGEN, Center for Aquaculture Technologies Partner to Develop Aquaculture Genotyping Tools

NEOGEN's (NEOG) Soleris Direct Yeast and Mold test is approved by the AOAC Institute to identify yeasts and molds in dried cannabis flower.

NEOGEN's (NEOG) Soleris Test to Serve the Cannabis Industry

LANSING, Mich., June 17, 2021 /PRNewswire/ -- NEOGEN Corporation's (NASDAQ: NEOG) Soleris® Direct Yeast and Mold test has received the Performance Tested MethodsSM Certification from the AOAC Research Institute's Emergency Response Validation Process for the enumeration of yeasts and molds in dried cannabis flower [9-tetrahydrocannabinol (THC) >0.3%].

AOAC Approves NEOGEN Soleris® Direct Yeast and Mold for Use in Cannabis

LEXINGTON, Ky., June 2, 2021 /PRNewswire/ -- NEOGEN Corporation (Nasdaq: NEOG) announced today that the U.S. EPA has granted an expedited, initial registration for NEOGEN to distribute NEOGEN® Viroxide Super™ disinfectant in the U.S., in part to help slow the spread of the virus that causes COVID-19.

EPA Approves NEOGEN® Viroxide Super™ for U.S. Distribution

LANSING, Mich., May 12, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that its Board of Directors has approved a two-for-one stock split.

NEOGEN Announces 2-for-1 Stock Split

LANSING, Mich., May 3, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that they have launched an improved version of their AccuPoint® Advanced sanitation monitoring system that is simpler to use and provides results that are easier to analyze.

NEOGEN launches improved sanitation monitoring system

Neogen (NEOG) Up 13.1% Since Last Earnings Report: Can It Continue?

Strong performance in both its Animal Safety and Food Safety segments during the fiscal third quarter pushes Neogen (NEOG) to a 52-week high.

News for Neogen Stock (NEOG)